The Physiological Chronobiome Modified by Age, Sex and Under Evoked Conditions
1 other identifier
interventional
48
1 country
1
Brief Summary
The investigators piloted the characterization of the human chronobiome. Now, this line of research is extended to explore physiological chronobiome modulated by sex, age and under evoked conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Jan 2020
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 5, 2020
CompletedFirst Submitted
Initial submission to the registry
January 6, 2020
CompletedFirst Posted
Study publicly available on registry
January 13, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 4, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 4, 2028
February 24, 2026
February 1, 2026
7 years
January 6, 2020
February 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percent difference in the number of proteins with post-translational modifications found in blood samples from young versus old participants
High-throughput proteomics analysis determines the number of proteins with and without post-translational modifications. This will explore what effect age has on the number of proteins with post-translational modifications.
48 hours
Secondary Outcomes (8)
Percent difference in the number of proteins with post-translational modifications found in blood samples from female versus male participants
48 hours
Percent difference in the number of proteins with post-translational modifications found in blood samples from female versus male participants and by age
48 hours
Percent difference in environmental light exposure between young versus old participants
48 hours
Percent difference in environmental light exposure between young versus old participants and by sex
48 hours
Percent difference in physical activity between young versus old participants
48 hours
- +3 more secondary outcomes
Study Arms (1)
Fatty meal
OTHERTo study how a fatty meal modifies the physiological chronobiome in young and old, an isocaloric controlled liquid high fat meal (ICLHFM) will be consumed within 5 min. The ICLHFM contains an equivalent to 35% of the estimated total daily energy requirements (TDE), 60% of kcal delivered from fat while 13% come from protein and 27 % from carbohydrate.
Interventions
The intervention consists of a fatty meal
Eligibility Criteria
You may qualify if:
- Young: 18-30 years of age, Old: 55-75 years of age
- Apparent healthy
- BMI (body mass index) up to 27.4
- Upper arm with intact skin, i.e. without areas of breached or injured skin visible, for ambulatory blood pressure (ABP) measurements,
- Own and use a smartphone.
You may not qualify if:
- History of severe psychiatric illness or cognitive conditions, for example (mania, schizophrenia, or mental retardation;
- Shift work, defined as recurring work between 22:00-05:00;
- A diagnosis of clinically significant obstructive sleep apnea;
- Serum creatinine \> 1.5 mg/dl in men or \>1.3 mg/del in women;
- Significant liver disease (\>3x upper limit of normal);
- Diabetes mellitus;
- Past diagnosis of gastroesophageal reflux disease,
- Transmeridian travel across ≥3 time zones in the two weeks before the 48hr deep phenotype sessions;
- Use of oral or intravenous antibiotics in the 6 months prior to enrollment;
- Subjects, who have received an experimental drug, used an experimental medical device within 30 days prior to screening, or who gave a blood donation of ≥ one pint within 8 weeks prior to screening;
- \> 2 drinks of alcohol per day;
- Use of drugs assessed in the urinary drug test;
- Nursing or pregnant (pregnancy will be repeatedly assessed at the beginning of each of the four inpatient visits, i.e. prior to the start of blood draws);
- Use of pacemaker or implantable Cardioverter Defibrillator (ICD);
- Bilateral mastectomy;
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania, 19104, United States
Related Publications (1)
Skarke C, Lahens NF, Rhoades SD, Campbell A, Bittinger K, Bailey A, Hoffmann C, Olson RS, Chen L, Yang G, Price TS, Moore JH, Bushman FD, Greene CS, Grant GR, Weljie AM, FitzGerald GA. A Pilot Characterization of the Human Chronobiome. Sci Rep. 2017 Dec 7;7(1):17141. doi: 10.1038/s41598-017-17362-6.
PMID: 29215023BACKGROUND
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Garret A FitzGerald, MD
University of Pennsylvania
- PRINCIPAL INVESTIGATOR
Carsten C Skarke, MD
University of Pennsylvania
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- ADJ Research Associate Professor
Study Record Dates
First Submitted
January 6, 2020
First Posted
January 13, 2020
Study Start
January 5, 2020
Primary Completion (Estimated)
January 4, 2027
Study Completion (Estimated)
June 4, 2028
Last Updated
February 24, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share